PROFILE SUMMARY

Dr. Muhammad Tariq Khan, a distinguished professional with a Ph.D. in Pharmacy (Pharmaceutical Chemistry) obtained through the HEC-Indigenous Scholarship Program at Riphah International University in 2021. His multifaceted career encompasses roles as a National Sales Manager, Product Manager, Lecturer, and Assistant Professor within the domains of pharmaceutical marketing and academia. Dr. Khan’s extensive expertise is emphasized by his significant contributions to medicinal chemistry, organic synthesis, molecular modeling, and docking, as well as molecular pharmacology. His research primarily revolves around the organic synthesis of lead molecules and organic moieties. His commitment to advancing knowledge is evident through numerous post-graduate research projects that he has successfully supervised in collaboration with esteemed colleagues. Dr. Muhammad Tariq Khan’s research has not only enriched the academic community but has also opened new avenues in the realm of pharmaceuticals, contributing to advancements with far-reaching implications. His dedication to academia and research exemplifies a commitment to excellence, making him an asset to the field.

TEACHING EXPERIENCE
Assistant Professor	Capital University of Science and Technology (CUST), Islamabad	Since – 2021
Assistant Professor	Margalla College of Pharmacy, Rawalpindi	2018 – 2018

INDUSTRIAL EXPERIENCE
Product Manager	UniMark Pharmaceuticals Ltd.	2013 – 2014
Product Specialist	3A Pharmaceuticals Ltd.	2012 – 2012

MEMBERSHIP OF PROFESSIONAL BODIES
PPC	Member Punjab Pharmacy Council, Lahore
PPA	Member Pakistan Pharmacist Association

RESEARCH AREAS / INTERESTS
1.	Organic Synthesis
2.	Drug Designing and Development
3.	Pharmaceutical Chemistry
4.	Virtual Drug Designing and In-Silico Screening

SR.	JOURNAL PUBLICATIONS	YEAR
1	A. Bukhari, H. Nadeem, S. Sarwar, I. Abbasi, M. T. Khan, I. Hamid, U. Bukhari. “Exploring Therapeutic Potential of 1,3,4-Oxadiazole Nucleus as Anticancer Agents: A Mini-Review.” Medicinal Chemistry	2022
2	A.M. Zubair, M.N.H. Malik, W. Younis, M.A.H. Malik, S. Jahan, I. Ahmed, A. Yuchi, M.N. Mushtaq, R. Tahir, M.B. Sarwar, and M. Roman. A. A. Khan, M. N Tahir, M. T. Khan, H. A. A, Kharl, G. Kamran, A.A Albegali1, A. Imran. “Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.” Inflammopharmacology, vol. 16, pp.1-15	2022
3	A.Batool, G.A. Miana, M. Alam, M. T Khan, M. Muddassir, W. Zaman, Saifullah, A. Aman, A. Khusroo, M. V. Arasu, N.A. Al-Dhabi, K.C. Choi, and M. U. K. Shahibzada. “Bioassay-guided fractionation and isolation of Arctigenin from Saussurea heteromalla for in vitro and in silico cytotoxic activity against HeLa cells.” Physiological and Molecular Plant Pathology, 101749	2021
4	N.S. Malik, M. Ahmad, M.S. Alqahtani, A. Mahmood, K. Barkat, M.T. Khan, U.R. Tulain, and A. Rashid, “β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation”, Drug Delivery, vol. 28, no. 1, pp. 1093-1108	2021
5	M. T. Khan, H. Nadeem, A. S. Sheikh, N. S. Malik, M. Rizwan, M. Imran, I. Javed. A. Khan, and M. Abbas, “Amino acid derivatives of 2-Mercaptobenzimidazoles suppress cytokines at the site of inflammation and block gastric H/K ATPase”, Pakistan Journal of Pharmaceutical Sciences, vol. 34, no. 3, pp. 1157-1163	2021
6	H. R. Afzal., N. U. H. Khan., K. Sultana., A. Mubashir., A. Lareb., A. Khan., M. T. Khan., and M. Imran, “Schiff bases of pioglitazone provide better antidiabetic and potent antioxidant effect in a streptozotocin–nicotinamide-induced diabetic rodent model”, ACS Omega, vol. 06, no. 06, pp. 4470-4479	2021
7	M. T. Khan, H. Nadeem, A. U. Khan, M. Abbas, M. Arif, N.S. Shamshad, Z. Malik, and I. Javed, “Amino acid conjugates of 2-mercaptobenzimidazole provide better anti-inflammatory pharmacology and improved toxicity profile”, Drug Development Research, vol. 81, no. 08,pp. 1057-1072	2020
8	A. M. Alvi, L. T. A. Kury, M. U. Ijaz, F. A. Shah, M. T. Khan, A. S. Sheikh, H. Nadeem, A. Khan, A. Zeb, and S. Li, “Post-treatment of synthetic polyphenolic 1,3,4 oxadiazole compound A3, attenuated ischemic stroke-induced neuroinflammation and neurodegeneration”, Biomolecules, vol. 10, no. 1, pp. 816	2020
9	S. Iqbal, F. A. Shah, K. Naeem, H. Nadeem, S. Sarwar, Z. Ashraf, M. Imran, T. Khan, T. Anwar, and S. Li,“Succinamide derivatives ameliorate neuroinflammation and oxidative stress in scopolamine-induced neurodegeneration”, Biomolecules, vol. 10, no. 3, pp. 443	2020
10	M. T. Khan, M. T. Razi, S. U. Jan, M. Mukhtiar, R. Gul, I. Ullah, A. Hussain, A. M. Hashmi, M. T. Ahmad, N. A. Shahwani, and I. Rabbani, “Synthesis characterization and antihypertensive activity of 2-Phenyl substituted benzimidazoles”, Pakistan Journal of Pharmaceutical Sciences, vol. 31, no.3, pp. 1067-1074	2018
11	M. Hanif, H. U. Khan, S. Afzal, M. T. Khan, K. Afzal, and N. Iqbal, “Sustained release ivabradine lipospheres from camauba wax/stearic acid blend: formulation, evaluation, and optimization by central composite design”, Latin American Journal of Pharmacy, vol. 36, no. 1, pp. 25-36	2017
12	H. Khan, A. Mahmood, S. Maheen, R. M. Sarfaraz, A. Youchi, A. Shameem, M. Akhtar, H. Ahsen, M. T. Khan, M. Khalil, and T. M. Rana, “Formulation and in vitro evaluation of novel antidiabetic orodispersible tablets using kyron-t134 and crosscaramellose sodium as superdisintegrants”, Latin American Journal of Pharmacy, vol. 33, no. 4, pp. 631-639	2014
13	M. T. Razi, I. Javed, M. Z. Choudhary, M. T. Khan, and N. Mukhtar, “Effect of ketoprofen on lactic dehydrogenase from human platelets”, Advances in Clinical and Experimental Medicine, vol. 23, no. 3, pp. 377-380	2013